Acute Crit Care.  2024 Aug;39(3):439-440. 10.4266/acc.2024.00934.

New applications of non-pharmacological therapy for reducing anxiety and depression: a component of comprehensive heart failure treatment

• Kim MS

• KMID: 2563533
• DOI: http://doi.org/10.4266/acc.2024.00934

Reference

1. Aloran AA, Jarrah SS, Ahmed FR, AbuRuz ME. A quasi-experimental study to assess the effect of Benson’s relaxation on anxiety and depression among patients with heart failure in Jordan. Acute Critic Care. 2024; 39:430–8.

2. Maeda D, Fujimoto Y, Nakade T, Abe T, Ishihara S, Jujo K, et al. Frailty, sarcopenia, cachexia, and malnutrition in heart failure. Korean Circ J. 2024; 54:363–81.

3. Vitale C, Spoletini I, Rosano GM. The dual burden of frailty and heart failure. Int J Heart Fail. 2024; 6:107–16.

4. Uchmanowicz I, Gobbens RJ. The relationship between frailty, anxiety and depression, and health-related quality of life in elderly patients with heart failure. Clin Interv Aging. 2015; 10:1595–600.

5. Warraich HJ, Kitzman DW, Whellan DJ, Duncan PW, Mentz RJ, Pastva AM, et al. Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction. Circ Heart Fail. 2018; 11:e005254.

6. Meng C, Chai K, Li YY, Luo Y, Wang H, Yang JF. Prevalence and prognosis of frailty in older patients with stage B heart failure with preserved ejection fraction. ESC Heart Fail. 2023; 10:1133–43.